Stocks To Buy Now

Blog


DGE’s Medical Publication & Scientific Communications Summit Confronts the Biggest Challenges in Patient Relationships and Medical Misinformation

The Medical Publication and Scientific Communications Summit explores how communications and information professionals can convey crucial information to HCP decision-makers and non-expert audiences in a transparent, credible, and unbiased manner. The summit is organized at a crucial time when there is mistrust and misinformation in the medical industry. Industry thought leaders will offer their valuable advice on best practices for communicating information effectively to build trusted long-term relationships with patients. They will provide insights on ways of refining drug information to improve relationships with patients, which in turn will benefit patient outcomes. The event is hosted by Dynamic Global Events (“DGE”), a life science leader in organizing B2B events. Their portfolio caters to the informational and networking needs of the pharmaceutical, biotechnology, healthcare, medical devices, and allied industries.  The program focuses on new publication methods that allow for communicating with patients in a simple language that is transparent and reliable. Important topics of discussion:
  • Understanding patient expectations in digital space
  • Predicting, understanding, and mitigating medical misinformation
  • Uses for artificial intelligence in medical publishing
  • The importance of PLS Summary in clinical research and medical literature
  • Improving your publication partnerships
  • Incorporating DE&I best practices into publication methods
The event is designed for medical device, pharma, and biotech professionals. This program will also benefit medical publication planning solutions and service providers and medical/science communications solutions and service providers. To learn more, please visit https://ibn.fm/tl71p.

From Our Blog

Heartbeam Inc. (NASDAQ: BEAT) Partners with Mount Sinai to Accelerate AI-ECG Development and Validation

March 24, 2026

HeartBeam (NASDAQ: BEAT) recently announced a collaboration with Mount Sinai aimed at advancing artificial intelligence-driven electrocardiogram technology, marking another step in the company’s push to expand its role in next-generation cardiac monitoring. The announcement highlights HeartBeam’s growing focus on artificial intelligence (“AI”)-enabled analysis and reinforces the relevance of its technology as healthcare increasingly shifts toward […]

Rotate your device 90° to view site.